期刊
THERAPEUTIC ADVANCES IN GASTROENTEROLOGY
卷 5, 期 6, 页码 403-420出版社
SAGE PUBLICATIONS LTD
DOI: 10.1177/1756283X12453637
关键词
Clostridium difficile; fecal bacteriotherapy; fecal flora; fecal flora reconstitution; fecal microbiota transplantation; fecal transplant; recurrent Clostridium difficile infection; stool transplantation
Clostridium difficile infection rates are Climbing in frequency and severity, and the spectrum of susceptible patients is expanding beyond the traditional scope of hospitalized patients receiving antibiotics. Fecal microbiota transplantation is becoming increasingly accepted as an effective and safe intervention in patients with recurrent disease, likely due to the restoration of a disrupted microbiome. Cure rates of >90% are being consistently reported from multiple centers. Transplantation can be provided through a variety of methodologies, either to the lower proximal, lower distal, or upper gastrointestinal tract. This review summarizes reported results, factors in donor selection, appropriate patient criteria, and the various preparations and mechanisms of fecal microbiota transplant delivery available to clinicians and patients.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据